Intraductal Papillary Neoplasm of the Bile Duct

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) HER2-positive Intraductal Papillary Neoplasm of the Bile Duct Zanidatamab